Safety study on adverse events of zanubrutinib based on WHO-VigiAccess and FAERS databases
Qiaofang Liang(Fourth Affiliated Hospital of Guangxi Medical University), Hongwen Wu, Jiang Zeng(Guangxi Medical University), Ying He(Guangxi Medical University), Cong Liang(Guangxi Medical University), Xiaolin Liao(Hangzhou Hospital of Traditional Chinese Medicine), Yushen Huang(Fourth Affiliated Hospital of Guangxi Medical University)
Cited by 8
Related Papers
Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
|Frontiers in Pharmacology|2024|30
A Cross-Scale Method of Fabricating Transverse Electrode-Embedded Nanopore
|Nanoscience and Nanotechnology Letters|2016|0
Single Nucleotide Discrimination by <I>α</I>-Hemolysin Nanopore
|Nanoscience and Nanotechnology Letters|2016|0